Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-[18F]FACBC PET-CT for the Characterization of Primary Prostate Cancer

NCT00917865 is registered in ClinicalTrials.gov with David M. Schuster, MD as lead sponsor.

NCT NCT00917865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00917865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-[18F]FACBC PET-CT for the Characterization of Primary Prostate Cancer
Lead sponsor
David M. Schuster, MD
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2008
Completion date
January 31, 2013
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancers